查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1608808

2024 年正子断层扫描 (PET) 核子医学全球市场报告

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

正子断层扫描（PET）核子医学市场规模预计在未来几年将快速成长。 2028年，将以14.6%的复合年增长率成长至198.3亿美元。预测期内的预期增长是由研发投资增加、对微创诊断技术的需求不断增长、全球医疗基础设施的扩张、对食品和药品包装的需求不断增长以及癌症患病率上升所推动的。这段时期的主要趋势包括技术进步、多重模式诊断、人工智慧整合、数位 PET 系统的开发以及个人化医疗的进步。

慢性病盛行率的上升预计将在未来几年推动正子断层扫描（PET）核医市场的成长。慢性病是指通常持续三个月以上的长期健康状况，通常需要持续的医疗照护或限制日常活动。导致慢性病增加的因素包括老化、久坐的生活方式、不良的饮食习惯和环境风险。 PET 核子医学透过提供先进的影像技术，促进这些疾病的早期发现、准确诊断和持续监测，在慢性病的管理中发挥重要作用。例如，2024年2月，总部位于瑞士的政府间组织世界卫生组织（WHO）估计，2022年将有大约2000万新发癌症病例和970万新发癌症相关病例。此外，预计到 2050 年，新增癌症患者数量将超过 3,500 万，比 2022 年增加 77%。因此，慢性病盛行率的上升正在推动 PET 核医市场的扩张。

PET 核子医学领域的主要企业专注于开发技术先进的产品，例如提供代谢活动高解析度影像的 PET 切片扫描仪。 PET切片扫描仪是一种医学影像诊断设备，它整合了正子断层扫描（PET）和先进的计算技术，可产生体内代谢过程的详细截面影像，可用于检测疾病，尤其是癌症监测。例如，2024年7月，美国核子医学公司Positron公司宣布推出NeuSight PET-CT 3D64切片扫描仪。这款创新扫描仪在诊断影像和诊断准确性方面树立了新标准，将最尖端科技与患者舒适度和操作效率相结合。它旨在彻底改变心臟 PET 影像，以极具吸引力的价格分布提供卓越的价值和性能，适用于心臟病学和肿瘤学的临床研究。凭藉先进的资料收集和创新的识别技术，NeuSight PET-CT 提高了扫描速度和准确性，为各种分子成像应用和功能成像中的心臟、肿瘤和大脑研究提供全面的解剖覆盖。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球正子断层扫描 (PET) 核子医学市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球正子断层扫描 (PET) 核子医学市场表现：规模与成长，2018-2023 年
  • 全球正子断层扫描 (PET) 核子医学市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球正子断层扫描 (PET) 核子医学市场：按类型、性能和预测，2018-2023、2023-2028、2033
  • F-18
  • 铷82
  • 其他的
  • 全球正子断层扫描 (PET) 核子医学市场：按方法、性能和预测，2018-2023、2023-2028、2033
  • 诊断方法
  • 单光子发射电脑断层扫描
  • 正子断层扫描
  • 治疗方法
  • β射极法
  • α发射体法
  • 放射线治疗法
  • 全球正子断层扫描 (PET) 核子医学市场：按应用、性能和预测，2018-2023、2023-2028、2033
  • 肿瘤学
  • 心臟病学
  • 神经病学
  • 其他的
  • 全球正子断层扫描 (PET) 核子医学市场：按最终用户、效能和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断中心
  • 研究所

第 7 章 区域/国家分析

  • 全球正子断层扫描 (PET) 核子医学市场：按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球正子断层扫描 (PET) 核子医学市场：按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 正子断层扫描 (PET) 核子医学市场：竞争格局
  • 正子断层扫描 (PET) 核子医学市场：公司简介
    • Cardinal Health
    • Bayer AG
    • Medtronic plc
    • Siemens Healthineers AG
    • Fujifilm Holdings Corporation

第三十一章 其他重大及创新企业

  • Stryker Corporation
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Agfa HealthCare NV
  • Scripps Health
  • Shimadzu Corporation
  • Jubilant DraxImage Inc.
  • Neusoft Medical Systems Co. Ltd.
  • Toshiba America Medical Systems Inc.
  • Lantheus Holdings Inc.
  • Advanced Accelerator Applications
  • Bruker Corporation
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • Canon Medical Systems Corporation
  • Digirad Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20325

Positron Emission Tomography (PET) nuclear medicine is a medical imaging technique that utilizes radioactive materials to visualize and evaluate metabolic activities within the body. This method employs a small amount of radioactive material known as a radiotracer to detect changes at the cellular level, enabling physicians to diagnose diseases at an early stage.

The main types of positron emission tomography (PET) nuclear medicines include F-18, RB-82, and others. F-18, or fluorine-18, is a radioactive isotope frequently used in PET imaging. It is employed in various procedures, including diagnostic imaging, single photon emission computed tomography, therapeutic interventions, beta and alpha emitter procedures, and brachytherapy. F-18 is commonly applied in fields such as oncology, cardiology, and neurology. The primary end users of PET nuclear medicine include hospitals, diagnostic centers, and research institutions.

The positron emission tomography (PET) nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) nuclear medicine market statistics, including positron emission tomography (PET) nuclear medicine industry global market size, regional shares, competitors with a positron emission tomography (PET) nuclear medicine market share, detailed positron emission tomography (PET) nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) nuclear medicine industry. This positron emission tomography (PET) nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The positron emission tomography (PET) nuclear medicine market size has grown rapidly in recent years. It will grow from $10.03 billion in 2023 to $11.49 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth observed during the historic period can be attributed to the rising prevalence of cardiovascular diseases, increasing healthcare expenditures, a higher incidence of urological diseases, a growing geriatric population, and an increasing number of hospitals.

The positron emission tomography (PET) nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $19.83 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth during the forecast period can be attributed to increased investment in research and development, a rising demand for minimally invasive diagnostic techniques, the expansion of global healthcare infrastructure, growing demand for food and pharmaceutical packaging, and a higher prevalence of cancer. Key trends expected in this period include technological advancements, multi-modality diagnosis, the integration of artificial intelligence, the development of digital PET systems, and the advancement of personalized medicine.

The rising incidence of chronic diseases is projected to drive the growth of the positron emission tomography (PET) nuclear medicine market in the coming years. Chronic diseases are long-term health conditions that usually persist for three months or longer, often requiring continuous medical care or limiting daily activities. Factors contributing to the increase in chronic diseases include an aging population, sedentary lifestyles, poor dietary habits, and environmental risks. PET nuclear medicine plays a crucial role in managing chronic diseases by providing advanced imaging techniques that facilitate early detection, accurate diagnosis, and ongoing monitoring of these conditions. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental agency, reported that approximately 20 million new cancer cases and 9.7 million cancer-related deaths occurred in 2022. Furthermore, it is anticipated that by 2050, new cancer cases will surpass 35 million, marking a 77% increase from the 2022 figures. Thus, the rising prevalence of chronic diseases is driving the expansion of the PET nuclear medicine market.

Leading companies in the PET nuclear medicine sector are focusing on developing technologically advanced products, such as PET slice scanners, to deliver high-resolution images of metabolic activity. A PET slice scanner is a medical imaging device that integrates positron emission tomography (PET) with advanced computational techniques to generate detailed cross-sectional images of metabolic processes in the body, aiding in the detection and monitoring of diseases, especially cancer. For instance, in July 2024, Positron Corporation, a U.S.-based nuclear medicine company, introduced the NeuSight PET-CT 3D 64-slice scanner. This innovative scanner sets new standards for imaging and diagnostic accuracy, merging cutting-edge technology with patient comfort and operational efficiency. It aims to revolutionize cardiac PET imaging, providing exceptional value and performance at an attractive price point, making it suitable for cardiology and oncology clinical studies. With advanced data acquisition and innovative identification technology, the NeuSight PET-CT enhances both scanning speed and accuracy, offering comprehensive anatomical and functional imaging for heart, tumor, and brain studies across various molecular imaging applications.

In February 2023, Lantheus Holdings Inc., a U.S.-based radiopharmaceutical company, acquired Cerveau Technologies Inc. for an undisclosed sum. This acquisition supports Lantheus's growth strategy by broadening its pipeline of radiopharmaceutical diagnostic imaging agents to include the most commonly used Tau PET imaging agent for Alzheimer's disease. Additionally, it strengthens its portfolio with numerous academic collaborations and pharmaceutical partnerships. Cerveau Technologies Inc. specializes in providing F-18 labeled positron emission tomography imaging agents that target Tau tangles associated with Alzheimer's disease.

Major companies operating in the positron emission tomography (PET) nuclear medicine market are Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd.

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) nuclear medicine marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) nuclear medicine marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) nuclear medicine market consists of sales of radiotracers, dose calibrators, injection systems, patient monitoring systems and simulation tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (PET) nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (PET) nuclear medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The positron emission tomography (PET) nuclear medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: F-18; Rb-82; Other Types
  • 2) By Procedure: Diagnostic Procedures; Single Photon Emission Computed Tomography Procedures; Positron Emission Tomography Procedures; Therapeutic Procedures; Beta Emitter Procedures; Alpha Emitter Procedures; Brachytherapy Procedures
  • 3) By Application: Oncology; Cardiology; Neurology; Other Applications
  • 4) By End User: Hospitals; Diagnostic Centers; Research Institutes
  • Companies Mentioned: Cardinal Health; Bayer AG; Medtronic plc; Siemens Healthineers AG; Fujifilm Holdings Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Nuclear Medicine Market Characteristics

3. Positron Emission Tomography (PET) Nuclear Medicine Market Trends And Strategies

4. Positron Emission Tomography (PET) Nuclear Medicine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Positron Emission Tomography (PET) Nuclear Medicine Market Size and Growth

  • 5.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

  • 6.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • F-18
  • Rb-82
  • Other Types
  • 6.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic Procedures
  • Single Photon Emission Computed Tomography Procedures
  • Positron Emission Tomography Procedures
  • Therapeutic Procedures
  • Beta Emitter Procedures
  • Alpha Emitter Procedures
  • Brachytherapy Procedures
  • 6.3. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Neurology
  • Other Applications
  • 6.4. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Institutes

7. Positron Emission Tomography (PET) Nuclear Medicine Market Regional And Country Analysis

  • 7.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market

  • 8.1. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Positron Emission Tomography (PET) Nuclear Medicine Market

  • 9.1. China Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 9.2. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Positron Emission Tomography (PET) Nuclear Medicine Market

  • 10.1. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Positron Emission Tomography (PET) Nuclear Medicine Market

  • 11.1. Japan Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 11.2. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Positron Emission Tomography (PET) Nuclear Medicine Market

  • 12.1. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market

  • 13.1. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market

  • 14.1. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 14.2. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market

  • 15.1. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 15.2. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Positron Emission Tomography (PET) Nuclear Medicine Market

  • 16.1. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Positron Emission Tomography (PET) Nuclear Medicine Market

  • 17.1. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Positron Emission Tomography (PET) Nuclear Medicine Market

  • 18.1. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Positron Emission Tomography (PET) Nuclear Medicine Market

  • 19.1. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Positron Emission Tomography (PET) Nuclear Medicine Market

  • 20.1. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market

  • 21.1. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 21.2. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Positron Emission Tomography (PET) Nuclear Medicine Market

  • 22.1. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Positron Emission Tomography (PET) Nuclear Medicine Market

  • 23.1. North America Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 23.2. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Positron Emission Tomography (PET) Nuclear Medicine Market

  • 24.1. USA Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 24.2. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Positron Emission Tomography (PET) Nuclear Medicine Market

  • 25.1. Canada Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 25.2. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Positron Emission Tomography (PET) Nuclear Medicine Market

  • 26.1. South America Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 26.2. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market

  • 27.1. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market

  • 28.1. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 28.2. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Positron Emission Tomography (PET) Nuclear Medicine Market

  • 29.1. Africa Positron Emission Tomography (PET) Nuclear Medicine Market Overview
  • 29.2. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape
  • 30.2. Positron Emission Tomography (PET) Nuclear Medicine Market Company Profiles
    • 30.2.1. Cardinal Health
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Fujifilm Holdings Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Positron Emission Tomography (PET) Nuclear Medicine Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Agfa HealthCare NV
  • 31.5. Scripps Health
  • 31.6. Shimadzu Corporation
  • 31.7. Jubilant DraxImage Inc.
  • 31.8. Neusoft Medical Systems Co. Ltd.
  • 31.9. Toshiba America Medical Systems Inc.
  • 31.10. Lantheus Holdings Inc.
  • 31.11. Advanced Accelerator Applications
  • 31.12. Bruker Corporation
  • 31.13. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 31.14. Canon Medical Systems Corporation
  • 31.15. Digirad Corporation

32. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Benchmarking

33. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Nuclear Medicine Market

35. Positron Emission Tomography (PET) Nuclear Medicine Market Future Outlook and Potential Analysis

  • 35.1 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer